Molecular BiologybioRxiv
Enhancing CRISPR deletion via pharmacological delay of DNA-PK
Núria Bosch-Guiteras, Tina Uroda, Hugo Guillen-Ramirez…·Rory Johnson
This paper shows that temporarily inhibiting DNA-PK increases CRISPR-Cas9 deletion efficiency by delaying NHEJ, improving experimental outcomes across multiple cell lines and guide RNAs.
13 citations